Lifeline Biotechnologies, Inc. (LLBO)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT

Lifeline Biotechnologies Company Description

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States.

Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women.

It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer.

The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.

Lifeline Biotechnologies, Inc.
Country United States
Founded 1981
Industry Medical Devices
Sector Healthcare
CEO James Holmes

Contact Details

Address:
1325 Airmotive Way
Reno, Nevada 89502
United States
Phone 775-852-3222
Website lbti.co

Stock Details

Ticker Symbol LLBO
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US53219E8084
SIC Code 3845

Key Executives

Name Position
James D. Holmes CPA, MBA Chairman, Chief Executive Officer and Treasurer
Dr. William H. Reeves Ph.D. Founder
Dr. Louis G. Keith M.D., Ph.D. Vice President, Medical Director, Secretary and Director